4//SEC Filing
KAY E GERALD 4
Accession 0001053310-22-000001
CIK 0001016504other
Filed
May 5, 8:00 PM ET
Accepted
May 6, 5:08 PM ET
Size
4.9 KB
Accession
0001053310-22-000001
Insider Transaction Report
Form 4
KAY E GERALD
DirectorCEO and President10% Owner
Transactions
- Award
Common Stock
2022-05-06$0.23/sh+100,000$23,000→ 5,345,889 total
Footnotes (1)
- [F1]100,000 common stock shares acquired upon exercise of stock option grant dated May 24, 2019.
Documents
Issuer
INTEGRATED BIOPHARMA INC
CIK 0001016504
Entity typeother
Related Parties
1- filerCIK 0001053310
Filing Metadata
- Form type
- 4
- Filed
- May 5, 8:00 PM ET
- Accepted
- May 6, 5:08 PM ET
- Size
- 4.9 KB